Canada wins $5m in Eli Lilly patent case

21-03-2017

Canada wins $5m in Eli Lilly patent case

mironovak / iStockphoto.com

The Canadian government has won nearly $5 million in an arbitration claim filed by Eli Lilly which alleged wrongful termination of its drug patents.


Canada, Eli Lilly, patent, arbitration, NAFTA, Strattera, Zyprexa, wrongful termination, International Centre for Settlement of Investment Disputes,

LSIPR